Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200
==========================================================================================================================

* Daruka Mahadevan
* Mark C. Lanasa
* Charles Farber
* Manjari Pandey
* Maria Whelden
* Susan J. Faas
* Terrie Ulery
* Anjli Kukreja
* Lan Li
* Camille L. Bedrosian
* Xiaoping Zhang
* Leonard T. Heffner